COVID-19 Vaccination

Infectious Diseases
0
Pipeline Programs
2
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
BretovameranN/A1 trial
Active Trials
NCT06613984Active Not Recruiting660Est. Dec 2026
M&
Merck & Co.RAHWAY, NJ
1 program
CONFIDENCEN/A4 trials
Active Trials
NCT06374134Not Yet Recruiting30Est. Feb 2025
NCT05891626Unknown429Est. Dec 2024
NCT05722652Completed667Est. Oct 2024
+1 more trials

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
PfizerBretovameran
Merck & Co.CONFIDENCE
Merck & Co.CONFIDENCE
Merck & Co.CONFIDENCE
Merck & Co.CONFIDENCE

Clinical Trials (5)

Total enrollment: 1,786 patients across 5 trials

NCT06613984PfizerBretovameran

Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran)

Start: Oct 2024Est. completion: Dec 2026660 patients
N/AActive Not Recruiting

The Impact of Community and Patient Engagement Practices on Vaccine Confidence in the United States

Start: Jun 2024Est. completion: Feb 202530 patients
N/ANot Yet Recruiting

Group Intervention on Vaccine Confidence

Start: Aug 2023Est. completion: Dec 2024429 patients
N/AUnknown

A Multicomponent Clinic-based Intervention to Promote COVID-19 Vaccine Intention and Uptake Among Diverse Youth and Adolescents

Start: Mar 2023Est. completion: Oct 2024667 patients
N/ACompleted

Social Media-based Vaccine Confidence and Hesitancy Monitoring

Start: Mar 2022Est. completion: Jun 20220
N/AWithdrawn

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space